For the quarter ending 2026-03-31, VMD had -$3,739K decrease in cash & cash equivalents over the period. $1,359K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Income from equity method investments | - | 0 | 0 | 0 |
| Distributions of earnings received from equity method investments | - | 0 | 0 | 0 |
| Net income | 2,713 | 5,816 | 3,600 | 5,960 |
| Depreciation and amortization | 7,621 | 7,570 | 7,539 | 13,504 |
| Deferred income tax expense (benefit) | - | 380 | 4,690 | -1,961 |
| Loss (income) from debt investment | - | 0 | 0 | 0 |
| Stock-based compensation expense | 2,451 | 2,300 | 2,180 | 4,652 |
| Loss (gain) on disposal of property and equipment | -356 | -289 | -476 | 3,004 |
| Amortization of deferred financing costs | 66 | 107 | 57 | 64 |
| Accounts receivable, net | 5,593 | -1,828 | -968 | 1,638 |
| Inventory | 136 | -222 | 159 | 4 |
| Prepaid expenses and other assets | -389 | -123 | 476 | 150 |
| Trade payables | 1,582 | -288 | -831 | 1,598 |
| Deferred revenue | -41 | -263 | 123 | 499 |
| Accrued liabilities | -2,602 | -1,329 | 3,563 | -1,979 |
| Income tax payable/receivable | 1,265 | 1,686 | -3,363 | -2,433 |
| Net cash provided by operating activities | 8,071 | 18,441 | 18,367 | 15,108 |
| Purchase of property and equipment | 6,712 | 8,737 | 7,636 | 23,612 |
| Investment in equity investments | - | 0 | - | - |
| Cash paid for acquisitions, net of cash acquired | - | 0 | 26,332 | 0 |
| Proceeds from sale of debt security | - | 0 | - | - |
| Proceeds from sale of property and equipment | 1,227 | 1,125 | 1,671 | 13,355 |
| Net cash used in investing activities | -5,485 | -7,612 | -32,297 | -10,257 |
| Proceeds from term notes | - | 0 | 9,000 | - |
| Principal payments on term notes | - | 246 | 264 | 220 |
| Proceeds from exercise of options | 526 | 0 | 71 | 1,368 |
| Proceeds from revolving credit facilities | - | 0 | 13,000 | 0 |
| Principal payments on term notes | 3,242 | 8,000 | 5,000 | - |
| Payments for debt issuance costs | - | 115 | 0 | 0 |
| Shares redeemed to pay income tax | 1,996 | 2 | 101 | 1,631 |
| Payments for share repurchase programs | 1,439 | 0 | 11,561 | 1,664 |
| Repayments of finance lease liabilities | 0 | 0 | 15 | 35 |
| Distributions to non-controlling interest | 174 | 88 | 93 | 193 |
| Net cash used in financing activities | -6,325 | -8,451 | 5,037 | -2,375 |
| Net decrease in cash and cash equivalents | -3,739 | 2,378 | -8,893 | 2,476 |
| Cash and cash equivalents at beginning of year | 13,501 | 11,123 | 17,540 | - |
| Cash and cash equivalents at end of period | 9,762 | 13,501 | 11,123 | - |
VIEMED HEALTHCARE, INC. (VMD)
VIEMED HEALTHCARE, INC. (VMD)